Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jun 2

PMID 34067256

Citations 18

Authors

Andy Ruiz

Yadira Palacios

Irene Garcia

Leslie Chavez-Galan

Affiliations

Soon will be listed here.

Abstract

Tumor necrosis factor (TNF) is one of the main cytokines regulating a pro-inflammatory environment. It has been related to several cell functions, for instance, phagocytosis, apoptosis, proliferation, mitochondrial dynamic. Moreover, during mycobacterial infections, TNF plays an essential role to maintain granuloma formation. Several effector mechanisms have been implicated according to the interactions of the two active forms, soluble TNF (solTNF) and transmembrane TNF (tmTNF), with their receptors TNFR1 and TNFR2. We review the impact of these interactions in the context of mycobacterial infections. TNF is tightly regulated by binding to receptors, however, during mycobacterial infections, upstream activation signalling pathways may be influenced by key regulatory factors either at the membrane or cytosol level. Detailing the structure and activation pathways used by TNF and its receptors, such as its interaction with solTNF/TNFRs versus tmTNF/TNFRs, may bring a better understanding of the molecular mechanisms involved in activation pathways which can be helpful for the development of new therapies aimed at being more efficient against mycobacterial infections.

Citing Articles

Inflammation-Induced Nitric Oxide Synthase May Mediate the Acute Hypotensive Effect of ST36 Stimulation.

Lei Q, Yue X, Sun X, Zhu L, Liu S, Hong H J Inflamm Res. 2025; 18:2717-2731.

PMID: 40046680 PMC: 11880688. DOI: 10.2147/JIR.S494037.

The human-specific noncoding RNA functions at the intersection of sexually dimorphic pathways in inflammation, senescence, and metabolism.

Kennicott K, Liang Y FASEB Bioadv. 2025; 7(2):e1479.

PMID: 39917395 PMC: 11795277. DOI: 10.1096/fba.2024-00101.

Exploring TNFR1: from discovery to targeted therapy development.

Li Y, Ye R, Dai H, Lin J, Cheng Y, Zhou Y J Transl Med. 2025; 23(1):71.

PMID: 39815286 PMC: 11734553. DOI: 10.1186/s12967-025-06122-0.

Transcriptional Activity of Tumor Necrosis Factor Alpha Genes and Their Receptors in Patients with Varying Degrees of Coronary Artery Disease.

Potyka K, Dabek J Int J Mol Sci. 2024; 25(23).

PMID: 39684812 PMC: 11641606. DOI: 10.3390/ijms252313102.

Unlocking the Mechanisms of Hidradenitis Suppurativa: Inflammation and miRNA Insights.

Ames E, Sanders M, Jacobs M, Vida T Clin Cosmet Investig Dermatol. 2024; 17:2829-2846.

PMID: 39677852 PMC: 11646389. DOI: 10.2147/CCID.S483871.

References

Reddy P, Slack J, Davis R, Cerretti D, Kozlosky C, Blanton R . Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem. 2000; 275(19):14608-14. DOI: 10.1074/jbc.275.19.14608. View

Richter F, Seifert O, Herrmann A, Pfizenmaier K, Kontermann R . Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. MAbs. 2019; 11(4):653-665. PMC: 6601568. DOI: 10.1080/19420862.2019.1596512. View

Kundu M, Pathak S, Kumawat K, Basu S, Chatterjee G, Pathak S . A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat Immunol. 2009; 10(8):918-26. DOI: 10.1038/ni.1754. View

Antoni C, Braun J . Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol. 2002; 20(6 Suppl 28):S152-7. View

Chavez-Galan L, Vesin D, Segueni N, Prasad P, Buser-Llinares R, Blaser G . Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model. Am J Pathol. 2016; 186(9):2364-77. DOI: 10.1016/j.ajpath.2016.05.015. View

Cao Y, Li Y, Lv D, Chen X, Chen L, Zhu Z . Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by combination of surface plasmon resonance biosensor and UPLC-MS. Anal Bioanal Chem. 2016; 408(19):5359-67. DOI: 10.1007/s00216-016-9633-6. View

Hurtado O, Cardenas A, Lizasoain I, Bosca L, Leza J, Lorenzo P . Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology. 2001; 40(8):1094-102. DOI: 10.1016/s0028-3908(01)00035-1. View

Chen H, Xiao L, Zhang H, Liu N, Liu T, Liu L . The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity. J Leukoc Biol. 2011; 89(6):917-26. DOI: 10.1189/jlb.1209812. View

Jiang Y, Yu M, Hu X, Han L, Yang K, Ba H . STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1. Cell Death Differ. 2017; 24(4):660-671. PMC: 5384023. DOI: 10.1038/cdd.2016.162. View

10.

Beg A, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996; 274(5288):782-4. DOI: 10.1126/science.274.5288.782. View

11.

Lee H, Park H, Jeon K, Jeong B, Hwang J, Lee J . QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment. PLoS One. 2015; 10(3):e0119260. PMC: 4352032. DOI: 10.1371/journal.pone.0119260. View

12.

Zheng Y, Saftig P, Hartmann D, Blobel C . Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J Biol Chem. 2004; 279(41):42898-906. DOI: 10.1074/jbc.M403193200. View

13.

Idress M, Milne B, Thompson G, Trembleau L, Jaspars M, Houssen W . Structure-Based Design, Synthesis and Bioactivity of a New Anti-TNFα Cyclopeptide. Molecules. 2020; 25(4). PMC: 7071015. DOI: 10.3390/molecules25040922. View

14.

Tartaglia L, WEBER R, Figari I, Reynolds C, Palladino Jr M, Goeddel D . The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A. 1991; 88(20):9292-6. PMC: 52700. DOI: 10.1073/pnas.88.20.9292. View

15.

Steeland S, Puimege L, Vandenbroucke R, Van Hauwermeiren F, Haustraete J, Devoogdt N . Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1. J Biol Chem. 2014; 290(7):4022-37. PMC: 4326813. DOI: 10.1074/jbc.M114.617787. View

16.

Jian J, Li G, Hettinghouse A, Liu C . Progranulin: A key player in autoimmune diseases. Cytokine. 2016; 101:48-55. PMC: 5303690. DOI: 10.1016/j.cyto.2016.08.007. View

17.

Nguyen X, Lang P, Lang K, Adam D, Fattakhova G, Foger N . Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood. 2011; 118(3):598-608. DOI: 10.1182/blood-2010-10-313643. View

18.

Cavadas M, Oikonomidi I, Gaspar C, Burbridge E, Badenes M, Felix I . Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE. Cell Rep. 2017; 21(3):745-757. PMC: 5656746. DOI: 10.1016/j.celrep.2017.09.074. View

19.

Dondelinger Y, Delanghe T, Rojas-Rivera D, Priem D, Delvaeye T, Bruggeman I . MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol. 2017; 19(10):1237-1247. DOI: 10.1038/ncb3608. View

20.

Chen Z, Wang T, Liu Z, Zhang G, Wang J, Feng S . Inhibition of Autophagy by MiR-30A Induced by Mycobacteria tuberculosis as a Possible Mechanism of Immune Escape in Human Macrophages. Jpn J Infect Dis. 2015; 68(5):420-4. DOI: 10.7883/yoken.JJID.2014.466. View